<DOC>
	<DOC>NCT01963780</DOC>
	<brief_summary>To evaluate the safety and effectiveness of the OCS™ Lung to recruit, preserve and assess donor lungs that may not meet current standard donor lung acceptance criteria for transplantation.</brief_summary>
	<brief_title>International EXPAND Lung Pivotal Trial</brief_title>
	<detailed_description>The OCS™ Lung is to be used to recruit, preserve and assess donor lungs that may not meet current standard donor lung acceptance criteria from one or more of the following characteristics: - Donor PaO2/FiO2 ≤ 300 mmHg; or - Expected ischemic time &gt; 6 hours; or - Donor after Cardiac Death (DCD donor); or - Donor age ≥55 years old</detailed_description>
	<criteria>At least one of the following: Donor PaO2/FiO2 ≤ 300 mmHg; or Expected ischemic time &gt; 6 hours; or Donor after Cardiac Death (DCD donor); or Donor age ≥55 years old • Presence of moderate to severe traumatic lung injury with air and/or blood leak Presence of confirmed active pneumonia or persistent purulent secretions on repeated bronchoscopy evaluation or ET suction Previous history of pulmonary disease Multiple transfusions of &gt;10 pRBCs units ABO incompatibility Tobacco history of &gt;20 pack years</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>lung transplantation</keyword>
	<keyword>lung preservation</keyword>
	<keyword>breathing lung transplant</keyword>
</DOC>